PTPN11 and myeloproliferative disorder: Infants with Noonan syndrome are at risk for several hematologic abnormalities including bleeding secondary to coagulation defects and myeloproliferative disorders mostly associated with PTPN11 mutations (Roberts et al., 2013; Strullu et al., 2014; Tartaglia et al., 2003).